Inconsistent platelet-rich plasma product from devices cleared by the US FDA: A retrospective review of clinic data - 25/02/21

Meyeneobong Inyang, MD ^a, Javed A. Shaik, PhD ^a, Noora Hussain, BS ^b, Maria Hordinsky, MD ^a, Neil Sadick, MD ^{a, c, d}, Graham Gregorich, BS ^e, Jessica Asiala, BS ^e, Rebecca Freese, MS ^f, Ronda S. Farah, MD ^{a, ⁎}

^a Department of Dermatology, University of Minnesota, Minneapolis, Minnesota 

^b College of Continuing and Professional Studies, Minneapolis, Minnesota 

^c Sadick Dermatology, New York, New York 

^d Weill Cornell Medical College, New York, New York 

^e Blood Bank Quality Center, University of Minnesota Medical Center, Minneapolis, Minnesota 

^f Biostatistical Design and Analysis Center, Clinical and Translational Science Institute, University of Minnesota, Minneapolis, Minnesota 

^∗Correspondence to: Ronda S. Farah, MD, Department of Dermatology, University of Minnesota, 516 Delaware St SE, MMC 98, Minneapolis, MN 55455Department of DermatologyUniversity of Minnesota516 Delaware St SE, MMC 98MinneapolisMN55455